Sign inJoin waitlistJoin the waitlist

Ilana Hull

Director of Clinical Innovations, IM-REP · UPMC Medical Education

Credentials: · · · · · ·

History

UPMC Medical Education · Yale-New Haven Hospital
Present

Addiction Medicine
UPMC Medical Education
2017–2018
Family Medicine
Providence Health & Services - Oregon
2014–2017
Oregon Hlth Sci Univ Sch of Med
2010–2014

Research

Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation
Case report · Journal of Addiction Medicine · 2023 · 13 citations
Implications of xylazine exposure in pregnancy: a narrative review
Review · Journal of Addictive Diseases · 2025 · First of 7 authors · 3 citations
In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction)
Substance use & addiction journal · 2024 · 3 citations

Margaret Shang
5 papers
Raagini Jawa
5 papers · 2 as a fellow
Jane Liebschutz
3 papers
Liz Krans
3 papers
Payel Roy
3 papers · 2 as a fellow
JB
Jenna Butner
2 papers
Kenichi Tamama
2 papers
Kimberly Sue
2 papers
Kinna Thakarar
2 papers
Lois Bangiolo
2 papers · 2 as a fellow
Brent Thiel
1 paper
CP
Catherine Pressimone
1 paper · 1 as a fellow

Grants

Effects of Xylazine Exposure on Maternal, Perinatal and Infant Outcomes
National Institute on Drug Abuse · R21
Contact PI · $439K · University of Pittsburgh at Pittsburgh
2025–2027

Clinical trials

Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
Principal investigator · Recruiting
Ilana Hull
2023–2026